Browsing Tag

Formulation/Drug Product Manufacturing

318 posts

Olon, Cambrex, Lonza, IDT Biologika, Catalent, and LSNE Expand
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Olon, Cambrex, Catalent, Lonza, IDT Biologika, and LSNE. Chemicals/Chemical API Manufacturing Olon Expands Microbial GMP Manufacturing Site in Italy…

Cambrex Agrees to Be Acquired for $2.4 Billion by Private Equity Firm Permira Funds
By

By
Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients and drug products, has signed a definitive agreement to be acquired by an affiliate of the Permira Funds, a private equity…

Lonza, Flamma, Regis, Fujifilm Irvine Scientific, and Catalent Expand
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Lonza, Flamma, Regis Technologies, Evotec, Fujifilm Irvine Scientific, GenScript Biotech, Catalent, GenScript Biotech, Wasdell and Marken. Chemicals/Chemical API Manufacturing…

Lonza To Acquire Sterile Mfg Site from Novartis
By

By
Lonza has entered into a binding contractual agreement for the purchase of a sterile drug-product fill–finish facility in Stein, Switzerland from Novartis. The sterile, multi-product facility currently serves as the…

Lonza, Piramal, LSNE, Tergus Pharma Expand; Aptar Makes Two Acquisitions
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Lonza, Piramal Pharma Solutions, Tergus Pharma, LSNE, Aptar, and Rentschler Fill Solutions. Chemicals/Chemical API Manufacturing Lonza To Expand HPAPI…

Thermo Fisher, Cambrex Expand; Lonza Carves Out Specialty Ingredients Segment
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Thermo Fisher, Cambrex, Lonza, Vetter, Sterling Pharma, Fujifilm, PCI Pharma Services, Particle Sciences, Vibologics, iBio, and Parexel. Chemicals/Chemical API…

Fujifilm Diosynth Biotechnologies, Recipharm and Aphena Expand
By

By
The latest news from CDMOs, CMOs, and suppliers, featuring news from Fujifilm Diosynth Biotechnologies and Recipharma.  Biologics manufacturing Fujifilm Diosynth Biotechnologies to Expand UK Site with New BioCampus Fujifilm Diosynth Biotechnologies,…

Catalent Plans $40-Million Expansion for Solid Dosage Facility
By

By
Catalent has announced it is investing up to $40 million at its manufacturing facility in Winchester, Kentucky to increase the site’s formulation and controlled-release tablet and capsule manufacturing capabilities and…

Vetter, Catalent, Cambrex and Sharp Expand
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Vetter, Catalent, Cambrex,  Sharp and Biotechpharma.  Chemicals/Chemical API Manufacturing Cambrex Completes Construction for High-Potency API Facility and QC Lab for…

Lonza Reorganizes; ACG Group, Wilmington PharmaTech Expand
By

By
The latest news from CDMOs, CMOS, and other suppliers featuring news from Wilmington PharmaTech, Insilico, ACG Group, Lonza Chemicals/Chemical API Manufacturing Wilmington PharmaTech To Invest $18 Million In New Research…